These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 9934808

  • 1. Comparison of Alprostadil (Caverject) and a combination of vasoactive drugs as local injections for the treatment of erectile dysfunction.
    Abdallah HM.
    Int Urol Nephrol; 1998; 30(5):617-20. PubMed ID: 9934808
    [Abstract] [Full Text] [Related]

  • 2. [Evaluation of 452 patients with erectile dysfunction treated by combinations of vasoactive agents by penile injection].
    Segenreich E, Israilov S, Shmueli J, Simon D, Baniel J, Livne P.
    Harefuah; 1998 May 01; 134(9):673-8, 750. PubMed ID: 10909609
    [Abstract] [Full Text] [Related]

  • 3. Efficiency and side effects of prostaglandin E1 in the treatment of erectile dysfunction.
    Waldhauser M, Schramek P.
    J Urol; 1988 Sep 01; 140(3):525-7. PubMed ID: 3045341
    [Abstract] [Full Text] [Related]

  • 4. Intracavernous injection of prostaglandin E1 in combination with papaverine: enhanced effectiveness in comparison with papaverine plus phentolamine and prostaglandin E1 alone.
    Floth A, Schramek P.
    J Urol; 1991 Jan 01; 145(1):56-9. PubMed ID: 1984099
    [Abstract] [Full Text] [Related]

  • 5. Prostaglandin E1 versus mixture of prostaglandin E1, papaverine and phentolamine in nonresponders to high papaverine plus phentolamine doses.
    Bechara A, Casabé A, Chéliz G, Romano S, Fredotovich N.
    J Urol; 1996 Mar 01; 155(3):913-4. PubMed ID: 8583605
    [Abstract] [Full Text] [Related]

  • 6. [3 years' experience with intracavernous auto-injection therapy].
    Weiske WH.
    Urologe A; 1989 Sep 01; 28(5):253-6. PubMed ID: 2815435
    [Abstract] [Full Text] [Related]

  • 7. [Intracavernous injection of vasoactive drugs for treating erectile impotence].
    Yasumoto R, Asakawa M, Kawashima H, Yoshimura R, Maekawa T, Kashiwara N, Tanaka H, Nishio S.
    Hinyokika Kiyo; 1988 Feb 01; 34(2):301-4. PubMed ID: 2454019
    [Abstract] [Full Text] [Related]

  • 8. Prostaglandin E1 versus phentolamine/papaverine for the treatment of erectile impotence: a double-blind comparison.
    Lee LM, Stevenson RW, Szasz G.
    J Urol; 1989 Mar 01; 141(3):549-50. PubMed ID: 2918589
    [Abstract] [Full Text] [Related]

  • 9. Papaverine-phentolamine and prostaglandin E1 versus papaverine-phentolamine alone for intracorporeal injection therapy: a clinical double-blind study.
    Shenfeld O, Hanani J, Shalhav A, Vardi Y, Goldwasser B.
    J Urol; 1995 Sep 01; 154(3):1017-9. PubMed ID: 7637045
    [Abstract] [Full Text] [Related]

  • 10. Comparison of a mixture of papaverine, phentolamine and prostaglandin E1 with other intracavernous injections.
    Meinhardt W, Lycklama à Nijeholt AA, Kropman RF, Vermeij P, Zwartendijk J.
    Eur Urol; 1994 Sep 01; 26(4):319-21. PubMed ID: 7713130
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Prostaglandin E1 with phentolamine for the treatment of erectile dysfunction.
    Meinhardt W, de la Fuente RB, Lycklama à Nijeholt AA, Vermeij P, Zwartendijk J.
    Int J Impot Res; 1996 Mar 01; 8(1):5-7. PubMed ID: 8735187
    [Abstract] [Full Text] [Related]

  • 13. A prospective randomized study to optimize the dosage of trimix ingredients and compare its efficacy and safety with prostaglandin E1.
    Seyam R, Mohamed K, Akhras AA, Rashwan H.
    Int J Impot Res; 2005 Mar 01; 17(4):346-53. PubMed ID: 15772683
    [Abstract] [Full Text] [Related]

  • 14. New developments in self-injection therapy for erectile dysfunction.
    Gingell JC.
    Br J Urol; 1998 Apr 01; 81(4):599-603. PubMed ID: 9598634
    [No Abstract] [Full Text] [Related]

  • 15. [Prostaglandin E1 in erectile dysfunction].
    Porst H.
    Urologe A; 1989 Mar 01; 28(2):94-8. PubMed ID: 2655258
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparative study of papaverine plus phentolamine versus prostaglandin E1 in erectile dysfunction.
    Bechara A, Casabé A, Chéliz G, Romano S, Rey H, Fredotovich N.
    J Urol; 1997 Jun 01; 157(6):2132-4. PubMed ID: 9146599
    [Abstract] [Full Text] [Related]

  • 18. An improved vasoactive drug combination for a pharmacological erection program.
    Bennett AH, Carpenter AJ, Barada JH.
    J Urol; 1991 Dec 01; 146(6):1564-5. PubMed ID: 1719248
    [Abstract] [Full Text] [Related]

  • 19. Erectile dysfunction: intracavernous treatment.
    Ledda A.
    Curr Med Res Opin; 2000 Dec 01; 16 Suppl 1():s59-62. PubMed ID: 11329824
    [Abstract] [Full Text] [Related]

  • 20. Experience with triple-drug therapy in a pharmacological erection program.
    Govier FE, McClure RD, Weissman RM, Gibbons RP, Pritchett TR, Kramer-Levien D.
    J Urol; 1993 Dec 01; 150(6):1822-4. PubMed ID: 8230514
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.